| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.73 | 0.007 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.39 | 0.007 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.37 | 0.04 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.29 | 0.05 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.26 | 0.4 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.26 | 5e-07 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.25 | 0.07 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.24 | 1e-05 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.23 | 0.5 |